Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
1.200
+0.010 (0.84%)
Dec 5, 2025, 4:00 PM EST - Market closed

Hoth Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Selling, General & Admin
6.194.974.216.136.574.41
Upgrade
Research & Development
5.673.253.744.937.532.89
Upgrade
Operating Expenses
11.868.227.9511.0714.17.3
Upgrade
Operating Income
-11.86-8.22-7.95-11.07-14.1-7.3
Upgrade
Interest & Investment Income
00.030.050.07-0.03
Upgrade
Other Non Operating Income (Expenses)
---0.45-0.060.02
Upgrade
EBT Excluding Unusual Items
-11.86-8.19-7.9-10.55-14.16-7.25
Upgrade
Gain (Loss) on Sale of Investments
-0.03-0-0.2-0.82-0.150.05
Upgrade
Pretax Income
-11.88-8.19-8.11-11.37-14.31-7.2
Upgrade
Net Income
-11.88-8.19-8.11-11.37-14.31-7.2
Upgrade
Preferred Dividends & Other Adjustments
----0--
Upgrade
Net Income to Common
-11.88-8.19-8.11-11.37-14.31-7.2
Upgrade
Shares Outstanding (Basic)
1263110
Upgrade
Shares Outstanding (Diluted)
1263110
Upgrade
Shares Change (YoY)
108.05%87.00%184.69%34.07%80.63%34.90%
Upgrade
EPS (Basic)
-1.01-1.28-2.38-9.50-16.02-14.56
Upgrade
EPS (Diluted)
-1.01-1.28-2.38-9.50-16.02-14.56
Upgrade
Free Cash Flow
-9.68-6.98-8.45-9.3-12.09-6.13
Upgrade
Free Cash Flow Per Share
-0.83-1.09-2.48-7.76-13.54-12.40
Upgrade
EBITDA
-----14.1-7.3
Upgrade
D&A For EBITDA
----00
Upgrade
EBIT
-11.86-8.22-7.95-11.07-14.1-7.3
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.